Apex, NC, United States of America

Michelle Brenda Pires

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michelle Brenda Pires

Introduction

Michelle Brenda Pires is a prominent inventor based in Apex, North Carolina. She has made significant strides in the field of biotechnology, particularly in the development of genetically-modified immune cells. With a total of three patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

One of her latest patents involves genetically-modified immune cells that express a microRNA-adapted shRNA (shRNAmiR). This invention focuses on reducing the expression of a target endogenous protein within immune cells. The methods she developed allow for the introduction of shRNAmiRs that specifically target these proteins, enabling stable knockdown of their expression. This innovative approach has the potential to enhance the effectiveness of immune responses in various therapeutic applications.

Career Highlights

Michelle is currently employed at Precision Biosciences, Inc., where she continues to push the boundaries of scientific research. Her work is characterized by a commitment to improving health outcomes through innovative biotechnological solutions.

Collaborations

Throughout her career, Michelle has collaborated with notable colleagues, including Aaron Martin and Jon E Chatterton. These partnerships have contributed to the success of her projects and the advancement of their shared goals in biotechnology.

Conclusion

Michelle Brenda Pires exemplifies the spirit of innovation in the field of biotechnology. Her contributions, particularly in the area of genetically-modified immune cells, are making a significant impact on medical research and treatment possibilities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…